Andrew John Whittle

Company: Boehringer Ingelheim

Job title: Director, BD&L

Seminars:

Shaping the Future of Antifibrotic Therapeutics with Exploration of Expansion Opportunities & Key Considerations 4:00 pm

This session will explore and evaluate emerging trends, identify innovative approaches to differentiate products and strategic insights on how to advance antifibrotic drug development and patient care across a broad spectrum of diseases. Examine the driving factors behind progress and how best to capitalize on these to explore your future expansion strategies.Read more

day: Day One